AVYCEF‑CV 325

Broad-Spectrum Power with Enhanced Oral Efficacy

AVYCEF‑CV 325 is a powerful broad-spectrum bactericidal antimicrobial, combining Cefixime with Clavulanic Acid to effectively combat a wide range of resistant bacterial infections. This advanced formulation is designed to deliver superior results in outpatient settings and is an ideal step-down therapy from injectable antibiotics.

🌿 Key Benefits

• ✅ Broad-Spectrum Bactericidal Action
  Effective against Gram-positive, Gram-negative, and β-lactamase–producing bacteria.
• ✅ Switch-Over Therapy Friendly
  Ideal for transitioning patients from parenteral (IV/IM) antibiotics to oral therapy without loss of efficacy.
• ✅ Superior Tissue Penetration
  Demonstrates greater tissue distribution than conventional cefixime, ensuring effective action at the infection site.
• ✅ Irreversible Suicidal Inhibitor
  Clavulanic acid acts as a β-lactamase inhibitor, irreversibly binding to and deactivating bacterial enzymes that resist amoxicillin.
• ✅ Extended Antibacterial Spectrum
  Enhances the potency of cefixime by preventing drug degradation, making it effective against resistant strains.

📦 Indications

• Respiratory tract infections
• Urinary tract infections
• ENT infections
• Skin & soft tissue infections
• Typhoid & gastrointestinal infections

Trust AVYCEF‑CV 325 for advanced oral antimicrobial therapy—strong, reliable, and resistance-proof.
📞 +91‑70425‑83594
📧 marketing@avystar.com
Avystar – Evoking Excellence in Every Formulation